Your session is about to expire
← Back to Search
Epic 30-day unplanned readmission risk score for Unplanned Hospital Readmissions
N/A
Waitlist Available
Led By Donna Williams, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a software tool that helps doctors identify patients who are likely to need to come back to the hospital after being discharged. The tool calculates a risk score and suggests additional care services for high-risk patients. The goal is to reduce unplanned readmissions by providing extra support to those who need it most.
Eligible Conditions
- Unplanned Hospital Readmissions
- High-risk patients for unplanned readmission
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 30
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 30
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of transitional and supportive care services (TSC) referrals by providers in the Control group
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Care Plus
Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Faith Health
+12 moreSecondary study objectives
30 day Readmission Rate
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: intervention group (IG)Experimental Treatment1 Intervention
The IG will consist of placing the Epic 30-day unplanned readmission risk score in the story board of providers - If a patient is identified as having a high risk of readmission defined as readmission risk \>20%, a link to transitional and supportive care services (TSC) will be appear in the story board
Group II: control group (CG)Active Control1 Intervention
The CG will have the same transitional and supportive care services (TSC) orders available to them; however, they will not have the risk of readmission score present in their workflow
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Epic 30-day unplanned readmission risk score
2023
N/A
~70
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,394 Previous Clinical Trials
2,459,968 Total Patients Enrolled
Donna Williams, MDPrincipal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You were diagnosed with a mental health condition during your hospital stay or during any later admissions.
Research Study Groups:
This trial has the following groups:- Group 1: intervention group (IG)
- Group 2: control group (CG)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger